Cogent Therapeutics Overview

  • Year Founded
  • 2011

Year Founded

  • Status
  • Acquired/​Merged

  • Latest Deal Type
  • M&A

  • Latest Deal Amount
  • $11M

Cogent Therapeutics General Information

Description

Provider of services related to ear, nose, and throat (ENT) disorders. The company is developer of innovative bio-material and device services focused on improving the lives of patients suffering ear, nose, and throat (ENT) disorders.

Contact Information

Website
www.cogent-tx.com
Ownership Status
Acquired/Merged
Financing Status
Formerly VC-backed
Corporate Office
  • 703 Sandoval Way
  • Hayward, CA 94544
  • United States
Primary Industry
Biotechnology
Acquirer
Entellus Medical
Vertical(s)
Life Sciences
Corporate Office
  • 703 Sandoval Way
  • Hayward, CA 94544
  • United States

Want detailed data on 3M+ companies?

What you see here scratches the surface

Request a free trial

Want to dig into this profile?

We’ll help you find what you need

Learn more

Cogent Therapeutics Valuation & Funding

Deal Type Date Amount Raised to Date Post-Val Status Stage
3. Merger/Acquisition 29-Jun-2016 $11M Completed Generating Revenue
2. Early Stage VC Completed Startup
1. Angel (individual) 30-Mar-2014 $1.5M $1.5M Completed Startup
To view Cogent Therapeutics’s complete valuation and funding history, request access »

Cogent Therapeutics Patents

  • 10

    Total Documents Applications and Grants

  • Total Patents Families

  • 5

    Granted

  • Pending

  • Expiring in next 12 mo

Cogent Therapeutics Recent Patent Activity

Publication ID Patent Title Status First Filing Date Technology (CPC) Citations
AU-201611580-S Nasal cavity delivery device Active 24-Sep-2015
AU-201611579-S Nasal cavity delivery device Active 24-Sep-2015
CA-167615-S Nasal cavity delivery device Active 24-Sep-2015
AU-201611578-S Nasal cavity delivery device Active 24-Sep-2015
AU-201611577-S Nasal cavity delivery device Active 24-Sep-2015
To view Cogent Therapeutics’s complete patent history, request access »

Cogent Therapeutics Former Investors (4)

Investor Name Investor Type Holding Investor Since Participating Rounds
Band of Angels Angel Group Minority
Angel (individual) Minority
Lymo Ventures Venture Capital Minority
Pond Capital Venture Capital Minority
To view Cogent Therapeutics’s complete investors history, request access »

Ready to get started?

Request a free trial

Cogent Therapeutics FAQs

  • When was Cogent Therapeutics founded?

    Cogent Therapeutics was founded in 2011.

  • Where is Cogent Therapeutics headquartered?

    Cogent Therapeutics is headquartered in Hayward, CA.

  • What industry is Cogent Therapeutics in?

    Cogent Therapeutics’s primary industry is Biotechnology.

  • Is Cogent Therapeutics a private or public company?

    Cogent Therapeutics is a Private company.

  • What is the current valuation of Cogent Therapeutics?

    The current valuation of Cogent Therapeutics is .

  • What is Cogent Therapeutics’s current revenue?

    The current revenue for Cogent Therapeutics is .

  • How much funding has Cogent Therapeutics raised over time?

    Cogent Therapeutics has raised $1.5M.

  • Who are Cogent Therapeutics’s investors?

    Band of Angels, , Lymo Ventures, and Pond Capital have invested in Cogent Therapeutics.

  • When was Cogent Therapeutics acquired?

    Cogent Therapeutics was acquired on 29-Jun-2016.

  • Who acquired Cogent Therapeutics?

    Cogent Therapeutics was acquired by Entellus Medical.

Data Transparency

  • Meet our data hygiene team

    Discover how our experts ensure you’re getting the most accurate financial data in the industry.

    Read blog »

  • How PitchBook sources data

    Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.

    Discover our process »